Construction of a new $95 million Coriell Institute Strategic Innovation Center is underway in Camden. The building is expected to open in early 2028. The location, which was announced in February, ...

A rebound in global biotech deals is set to accelerate as big pharmaceutical companies seek new sources of revenue, according to the International Biotechnology Trust Plc. The pace of dealmaking has ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — The German biotech Tubulis, which is designing a series of ...

October 15, 2025- (Investorideas.com Newswire), a go-to investing platform covering biotech and medtech stocks releases a news and trading alert for Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene ...

Biotech is "at the cusp of a golden age" in the U.S., and Illinois will capitalize on it by taking advantage of the changes on the horizon, like AI and quantum science, said John Crowley, president ...

For more than 55 years, Institutional Investor has delivered the news and analysis that investment professionals need to succeed and stay relevant. Our coverage of the global asset management industry ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The pharma giant is buying an ...

Evommune, which is developing drugs targeting the sources of chronic inflammatory diseases, filed for an initial public offering. The Palo Alto, Calif., company is seeking a New York Stock Exchange ...